Skip to main content

Table 1 Demographic and baseline characteristics

From: Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes

1.

No of eyes

28

2.

Age (mean)

58.89 years (range 36–82)

3.

Gender

22 males, 6 females

4.

Bilateral PCV + VH

4 (14.28 %)

5.

DM/duration

10 patients/13 years (range 3–25 years)

6.

Hypertension/duration

15 patients/10.5 years (range 1–36 years)

7.

Eye

13 OD, 15 OS

8.

Duration of symptoms in months

6.2 (range 1–48 months)

9.

Lens status

11 phakic, 6 pseudophakic, 1 aphakic

10.

Previous treatment

VR surgery (n = 3), IVB (n = 5), PDT (n = 3), Laser (n = 1), IVTA (n = 1), Oral steroids (n = 3)

11.

Fundus exam at presentation

No view (n = 21), hemorrhagic PED (n = 6), subretinal blood (n = 4), pigmentary changes (n = 1)

  1. PCV polypoidal choiroidal vasculopathy, VH vitreous hemorrhage, DM diabetes mellitus, VR vitreoretinal, IVB intravitreal bevacizumab, PDT photodynamic therapy, IVTA intravitreal triamcinolone acetonide, PED pigment epithelial detachment